Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 2 | 2017 | 100 | 0.650 |
Why?
|
| Ablation Techniques | 1 | 2017 | 11 | 0.570 |
Why?
|
| Cryosurgery | 1 | 2017 | 19 | 0.560 |
Why?
|
| Nephrectomy | 1 | 2017 | 47 | 0.560 |
Why?
|
| Laparoscopy | 1 | 2017 | 143 | 0.500 |
Why?
|
| Remission Induction | 1 | 2017 | 50 | 0.140 |
Why?
|
| Salvage Therapy | 1 | 2017 | 32 | 0.140 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Fournier Gangrene | 1 | 2016 | 4 | 0.140 |
Why?
|
| Reoperation | 1 | 2017 | 144 | 0.140 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 70 | 0.130 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 77 | 0.130 |
Why?
|
| Cystectomy | 1 | 2017 | 103 | 0.130 |
Why?
|
| Length of Stay | 1 | 2016 | 218 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 160 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 309 | 0.120 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 4 | 0.090 |
Why?
|
| Hepatic Stellate Cells | 1 | 2011 | 14 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2011 | 27 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2265 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 98 | 0.090 |
Why?
|
| Antioxidants | 1 | 2011 | 222 | 0.080 |
Why?
|
| Humans | 4 | 2017 | 26838 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2017 | 2441 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 1564 | 0.040 |
Why?
|
| American Cancer Society | 1 | 2017 | 4 | 0.040 |
Why?
|
| Aged | 2 | 2017 | 5162 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 89 | 0.030 |
Why?
|
| Medicaid | 1 | 2017 | 54 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 209 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 43 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 297 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 252 | 0.030 |
Why?
|
| Male | 3 | 2017 | 12859 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 758 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 1925 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2011 | 6 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 44 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 32 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 38 | 0.020 |
Why?
|
| United States | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 77 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 80 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 152 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 196 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 187 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 388 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 239 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 537 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 588 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 399 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 645 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 1536 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 6818 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 1339 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 7386 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 4401 | 0.010 |
Why?
|
| Female | 1 | 2017 | 14455 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 9949 | 0.010 |
Why?
|